SEC
SlamSEC
SearchBrowseEarnings

DEXCOM INC

Nasdaq:DXCM
Surgical & Medical Instruments & Apparatus·SAN DIEGO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1007 total)

TypeDateAccessionPeriodSize
8-K
Mar 2, 2026
0001093557-26-0000388-K
Feb 27, 2026
429.2 KB
4
Feb 26, 2026
0001093557-26-000034FORM 4
Feb 26, 2026
4.7 KB
3
Feb 26, 2026
0001093557-26-000032FORM 3
Feb 26, 2026
16.4 KB
8-K
Feb 26, 2026
0001093557-26-0000318-K
Feb 26, 2026
401.1 KB
4
Feb 17, 2026
0001485616-26-000002FORM 4
Feb 12, 2026
4.9 KB
10-K
Feb 12, 2026
0001093557-26-00002710-K
Dec 31, 2025
13.3 MB
8-K
Feb 12, 2026
0001093557-26-0000258-K
Feb 12, 2026
676.4 KB
144
Feb 12, 2026
0001959173-26-000899
—
4.8 KB
4
Feb 2, 2026
0001093557-26-000013FORM 4
Jan 29, 2026
7.8 KB
4
Feb 2, 2026
0001093557-26-000012FORM 4
Jan 29, 2026
6.8 KB
4
Feb 2, 2026
0001093557-26-000011FORM 4
Jan 29, 2026
20.2 KB
4
Feb 2, 2026
0001093557-26-000010FORM 4
Jan 29, 2026
7.0 KB
4
Feb 2, 2026
0001093557-26-000009FORM 4
Jan 29, 2026
20.0 KB
8-K
Jan 12, 2026
0001093557-26-0000038-K
Jan 7, 2026
425.7 KB
8-K
Dec 22, 2025
0001093557-25-0002918-K
Dec 19, 2025
426.4 KB
4
Nov 17, 2025
0001093557-25-000288FORM 4
Nov 14, 2025
5.8 KB
144
Nov 14, 2025
0001959173-25-006999
—
5.0 KB
4
Nov 12, 2025
0001093557-25-000286FORM 4
Nov 12, 2025
18.3 KB
144
Nov 12, 2025
0001959173-25-006930
—
4.2 KB
4
Nov 10, 2025
0001093557-25-000284FORM 4
Nov 10, 2025
21.3 KB
4
Nov 10, 2025
0001093557-25-000283FORM 4
Nov 10, 2025
19.2 KB
144
Nov 10, 2025
0001959173-25-006824
—
4.4 KB
10-Q
Oct 30, 2025
0001093557-25-00028010-Q
Sep 30, 2025
7.5 MB
8-K
Oct 30, 2025
0001093557-25-0002788-K
Oct 30, 2025
692.6 KB
SCHEDULE 13G/A
Oct 30, 2025
0000102909-25-000102
—
6.0 KB
25 filings shown

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.

CEO
Leach Jacob Steven